Meena Venkatachalam, MSc
Meena has over 10 years of experience in providing health economics and outcomes research consulting services to the biopharmaceutical industry.
At Precision, Meena focuses on advising clients on the development of robust HTA compliant cost-effectiveness and budget-impact models, early-stage model development plans, and payer-value tools. She has experience in a range of therapeutic areas including: oncology, cell/gene therapies, and cardiovascular disease. She has led the development of economic models for a range of markets including: US, Europe, Canada, and Asia Pacific.
Prior to joining Precision, Meena was at PAREXEL as a health economist also focusing on supporting the biopharmaceutical industry. Prior to PAREXEL, Meena was at Matrix Knowledge Group, a consultancy providing strategic support to NICE on both the development of cost-effectiveness models for public health interventions and the review of manufacture submissions to NICE on behalf of Evidence Review Groups.
MSc, London School of Economics